AbbVie ABBV
NYSE ABBV
$285.37 +1.97 (+0.70%)
As of: Oct 16, 2026 · 3:59 PM EDT

AbbVie (ABBV) Income towards Parent Company (2012 - 2026)

Updated

AbbVie (ABBV) reported Income towards Parent Company of $3.61 billion for Q2 2026, up 285.2% from $938 million a year earlier and up 419.9% from the prior quarter.

Analysis

AbbVie (ABBV) Income towards Parent Company (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, AbbVie's Income towards Parent Company came in at $6.31 billion, up 67.7% year-over-year; for FY2025, it came in at $4.23 billion, down 1.2% from FY2024.

  • Income towards Parent Company has declined for three consecutive years, with a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
  • By year, Income towards Parent Company came in at $4.28 billion in FY2024 (-12.0%), $4.86 billion in FY2023 (-58.9%), $11.84 billion in FY2022 (+2.5%) and $11.54 billion in FY2021 (+150.0%).
  • The Q2 2026 figure ranks as the highest quarterly Income towards Parent Company since Q3 2022.
  • Year over year, Income towards Parent Company gained in 1 of the last six quarters, with growth averaging 16.9%.
  • The high point for year-over-year Income towards Parent Company in five years was Q1 2024 (growth of 472.8%); the low point was Q1 2023 (a decline of 94.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $695 million (Q1 2026), $1.82 billion (Q4 2025) and $186 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.61 Bn
Mar 31, 2026 695.00 Mn
Dec 31, 2025 1.82 Bn
Sep 30, 2025 186.00 Mn
Jun 30, 2025 938.00 Mn
Mar 31, 2025 1.29 Bn
Dec 31, 2024 -22.00 Mn
Sep 30, 2024 1.56 Bn
Jun 30, 2024 1.37 Bn
Mar 31, 2024 1.37 Bn
Dec 31, 2023 822.00 Mn
Sep 30, 2023 1.78 Bn
Jun 30, 2023 2.02 Bn
Mar 31, 2023 239.00 Mn
Dec 31, 2022 2.47 Bn
Sep 30, 2022 3.95 Bn
Jun 30, 2022 924.00 Mn
Mar 31, 2022 4.49 Bn
Dec 31, 2021 4.04 Bn
Sep 30, 2021 3.18 Bn
API Access

AbbVie Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ABBV&period=max&api_key=YOUR_API_KEY